Trials
Search / Trial NCT06444347

Impact of Biosynthetic Mesh on Paraesophageal Hernia Repair

Launched by WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY · May 30, 2024

Trial Information

Current as of February 18, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at the use of a special type of mesh during surgery for hiatal hernias, which are conditions that can cause heartburn and other digestive issues. The goal is to see if using this mesh can help prevent these hernias from coming back after surgery. Participants in the study will be divided into two groups: one will have the surgery with the mesh, while the other will have the surgery without it.

To be eligible for this trial, participants should be adults aged 18 or older who have a diagnosed condition called gastroesophageal reflux disease (GERD) and are planning to have surgery for it. The study is currently recruiting participants and is open to all genders. Those who may not qualify include individuals with certain medical conditions, such as documented dementia, or those who are pregnant. If you choose to participate, you can expect to undergo surgery and contribute to important research that may help improve treatment options for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Documented diagnosis of gastroesophageal reflux disease
  • Adults aged 18 years or older
  • English speaking
  • Subject is planned to undergo surgery for reflux disease
  • Exclusion Criteria:
  • Physician deems the subject is unable to complete the study due to documented dementia.
  • Subject is undergoing emergent surgery.
  • Pregnancy
  • Patient has known allergy to tetracycline hydrochloride or kanamycin sulfate

Trial Officials

Rasa Zarnegar, MD

Principal Investigator

Weill Medical College of Cornell University

About Weill Medical College Of Cornell University

Weill Medical College of Cornell University is a leading academic institution dedicated to advancing medical research and education. As a prominent sponsor of clinical trials, it focuses on innovative healthcare solutions and the development of new therapies across various medical disciplines. The institution is committed to fostering collaborative research efforts that enhance patient care and improve health outcomes. With a robust infrastructure and a team of experienced researchers and clinicians, Weill Cornell aims to translate scientific discoveries into practical applications, ensuring a strong emphasis on ethical standards and regulatory compliance throughout the clinical trial process.

Locations

Saint Louis, Missouri, United States

New Orleans, Louisiana, United States

Burlington, Massachusetts, United States

Los Angeles, California, United States

New York, New York, United States

New York, New York, United States

New York, New York, United States

New York, New York, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0